Opus Genetics IRD Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $59.96M+33.0% | $45.09M+46.3% | $30.82M-5.0% | $32.43M-22.4% | $41.79M+37.8% | ||
| $1.73M-13.2% | $2M-31.6% | $2.92M-14.2% | $3.4M+10.4% | $3.08M-13.6% | ||
| $66.6M+33.1% | $50.04M+39.4% | $35.91M-6.6% | $38.44M-19.8% | $47.93M+30.9% | ||
| $186K-6.5% | $199K-6.1% | $212K-6.2% | $226K-5.4% | $239K-5.2% | ||
| $66.79M+32.9% | $50.24M+39.1% | $36.12M-6.6% | $38.67M-19.7% | $48.17M+30.7% | ||
| $4.42M+34.3% | $3.29M+37.5% | $2.4M+63.5% | $1.47M-39.7% | $2.43M-22.8% | ||
| $9.34M+20.0% | $7.78M-73.2% | $29.09M+44.1% | $20.19M-16.7% | $24.25M+115% | ||
| $1.2M— | —— | —— | —— | —— | ||
| $77.35M+198% | $25.99M-13.8% | $30.16M+42.3% | $21.19M-12.6% | $24.25M+115% | ||
| 125M0.0% | 125M0.0% | 125M0.0% | 125M0.0% | 125M+4,166,567% | ||
| -$254.12M-34.8% | -$188.59M-9.6% | -$172.07M-11.3% | -$154.61M-5.0% | -$147.19M-5.9% | ||
| -$45.84M-399% | $15.35M+157% | $5.97M-65.9% | $17.47M+244% | $5.07M-24.6% | ||
| $66.79M+32.9% | $50.24M+39.1% | $36.12M-6.6% | $38.67M-19.7% | $48.17M+30.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Opus Genetics's total assets?
- Opus Genetics (IRD) holds $66.8M in total assets, up 38.7% year over year.
- How much debt does Opus Genetics have?
- Opus Genetics carries $1.2M in total debt against -$45.8M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Opus Genetics have?
- Opus Genetics holds $60.0M in cash and equivalents.
- Can Opus Genetics cover its short-term obligations?
- Its current ratio is 7.13 — current assets exceed current liabilities.
- Where does Opus Genetics's balance sheet data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
